Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Data are from the most recent national surveys available in each country (see epidemiological tables on population surveys, EMCDDA statistical bulletin).
The age range is from between 15 and 18 to between 59 and 64. Variations in age ranges may slightly influence disparities between countries.
Belgium: 2001 15-64 y. n=7347; 15-34 y. n=2758; 15-24 y. n=1152
Czech Republic: 2002 18-64 y. n=2526; 18-34 y. n=1002; 18-24 y. n=389
Denmark: 2000 16-64 y. n=11825; 16-34 y. n=4141; 16-24 y. n=1754
Germany: 2003 18-59 y. n=8061; 18-34 y. n=3775; 18-24 y. n=1891
Greece: 2004 15-64 y. n=4351; 15-34 y. n=2620; 15-24 y. n=1785
Spain: 2001 15-64 y. n=14113; 15-34 y. n=6915; 15-24 y. n=3368
France: 2002 15-64 y. n=1744; 15-34 y. n=724; 15-24 y. n=345
Ireland: 2002/03 15-64 y. n=4925; 15-34 y. n=; 15-24 y. n=
Italy: 2003 15-54 y. n=; 15-34 y. n=5231; 15-24 y. n=2112
Latvia: 2003 15-64 y. n=; 15-34 y. n=; 15-24 y. n=
Hungary: 2003 18-54 y. n=; 18-34 y. n=2319; 15-24 y. n=943
Netherlands 2000/01 15-64 y. n=14045; 15-34 y. n=6687; 15-24 y. n=
Poland: 2002 16+ y. n=3148; 16-34 y. n=; 16-24 y. n=
Portugal: 2001 15-64 y. n=14184; 15-34 y. n=6406; 15-24 y. n=3099
Slovakia: 2002 18-64 y. n=1405; 18-34 y. n=; 18-24 y. n=
Finland: 2002 15-64 y. n=2377; 15-34 y. n=1240; 15-24 y. n=614
UK (E&W): 2003/04 16-59 y. n=24422; 16-34 y. n=8590; 16-24 y. n=5429
Norway: 1999 15-64 y. n=1803; 15-34 y. n=794; 15-24 y. n=
Sources:
Reitox national reports 2004, taken from population surveys reports or scientific articles. See also standard epidemiological tables in EMCDDA statistical bulletin